Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Soft Tissue Augmentation Resorbable Matrix

K-Number: K233203 · 2024-05-01

Decision Date2024-05-01
Product CodeNPL
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Soft Tissue Augmentation Resorbable Matrix is a medical device manufactured by Collagen Matrix, Inc.. It received FDA 510(k) clearance on 2024-05-01 under approval number K233203. The device is classified under product code NPL. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Soft Tissue Augmentation Resorbable Matrix?

Soft Tissue Augmentation Resorbable Matrix is a medical device that received FDA 510(k) clearance on 2024-05-01. It is manufactured by Collagen Matrix, Inc.. The 510(k) number is K233203.

When was Soft Tissue Augmentation Resorbable Matrix approved by the FDA?

Soft Tissue Augmentation Resorbable Matrix received FDA 510(k) clearance on 2024-05-01, under approval number K233203.

What company makes Soft Tissue Augmentation Resorbable Matrix?

Soft Tissue Augmentation Resorbable Matrix is manufactured by Collagen Matrix, Inc..

What is the FDA product code for Soft Tissue Augmentation Resorbable Matrix?

The FDA product code for Soft Tissue Augmentation Resorbable Matrix is NPL.

Related Clinical Trials

Related PubMed Literature

Other Devices by Collagen Matrix, Inc.

View all 16 devices →

Related Devices (Code: NPL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.